Advertisement
Product › Details
PolyPEG® technology
Next higher product group | PEG technology_o | |
Status | 2012-01-20 existent | |
Organisation | Warwick Effect Polymers Ltd. (WEP) | |
Group | Abzena (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for PEG technology_o
- [1] ProBioGen AG. (1/10/23). "Press Release: ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck Transposase Technology". Berlin....
- [2] ProBioGen AG. (2/11/22). "Press Release: ProBioGen Signs a Commercial License Agreement with AstraZeneca Providing their GlymaxX® Technology". Berlin....
- [3] ProBioGen AG. (4/28/20). "Press Release: ProBioGen AG Appoints Dr. Lutz Hilbrich as New Chief Executive Officer – Dr. Wieland Wolf Retires". Berlin & Cairo....
- [4] ProBioGen AG. (1/8/20). "Press Release: ProBioGen Inks Next Commercial GlymaxX License with Roche. ADCC-enhancement for Innovative Cancer Therapy". Berlin....
- [5] ProBioGen AG. (9/10/19). "Press Release: ProBioGen Licenses GlymaxX Technology to Bayer". Berlin....
- [6] ProBioGen AG. (1/3/19). "Press Release: ProBioGen’s GlymaxX ADCC Enhancement Technology Used by Betta Pharmaceuticals". Berlin....
- [7] ProBioGen AG. (11/6/18). "Press Release: ProBioGen Announces Successful Bispecific GlymaxX Development Project for Zymeworks". Berlin....
- [8] ProBioGen AG. (5/24/18). "Press Release: ProBioGen Announces Further Development Milestone for Use of Its GlymaxX Cancer Cell-killing Enhancement Antibody Technology with Merus N.V.". Berlin....
- [9] ProBioGen AG. (10/5/17). "Press Release: Chiome Bioscience Selects ProBioGen for GlymaxX Antibody Manufacturing Program". Berlin & Tokyo....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top